None listed
Conditions
Brief summary
The primary purpose of this trial is to evaluate the link between body composition and outcomes in pancreatic cancer. Who is it for? You may be eligible to participate in this study if you are aged 18 or over and have been diagnosed with pancreatic ductal adenocarcinoma within the last month. Study details All participants enrolled in this study will complete a number of assessments including hand grip strength testing, a questionnaire and lung function tests at enrolment and 3 and 6 months later. The researchers will also require access to CT scans which have been collected as a part of your cancer management. It is hoped that the findings from this study will inform researchers on the links between muscle mass and function, and cancer outcomes of chemotherapy toxicity and survival.
Interventions
This is an observational study, tracking muscle mass and strength during standard of care chemotherapy treatment. The muscle mass will be measured on standard of care CT scans. Muscle function will be assessed using grip strength measurement (1 minute) and peak expiratory flow measurement (2 minutes). An anorexia questionnaire will also be provided (2 minutes)
Sponsors
Monash Health
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
-Adult -Pancreatic ductal adenocarcinoma -Diagnosed with pancreatic cancer within the last month
Exclusion criteria
Neuromuscular disease
Outcome results
None listed